Reductions in medical visits and hospitalizations following berotralstat initiation in patients with hereditary angioedema in the United States.

Orladeyo (berotralstat) - BioCryst

http://www.ncbi.nlm.nih.gov/pubmed/40443005

Bruce L Zuraw; Colleen Spencer; Douglas T Johnston; François Laliberté; Julien Boudreau; Lorena Lopez-Gonzalez; Patrick Gillard; Sandra C Christiansen; Sandra Nestler-Parr; Sean D MacKnight

May 30, 2025